
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
07/16/2025 | Q2 | -- | $198.2M | $0.50 | -- | -- |
04/30/2025 | Q1 | -- | $183.6M | $0.45 | -- | -- |
01/29/2025 | Q4 | -- | $157.9M | $0.24 | -- | -- |
10/30/2024 | Q3 | -- | $181.4M | $0.47 | -- | -- |
06/30/2024 | Q2 | -- | $180.6M | $0.45 | -- | -- |
03/31/2024 | Q1 | -- | $187.3M | $0.38 | -- | -- |
12/31/2023 | Q4 | -- | $138.2M | $0.22 | -- | -- |
09/30/2023 | Q3 | -- | -- | $0.45 | -- | -- |
06/30/2023 | Q2 | -- | -- | $0.53 | -- | -- |
03/31/2023 | Q1 | -- | -- | $0.45 | -- | -- |
12/31/2022 | Q4 | -- | -- | $0.36 | -- | -- |
09/30/2022 | Q3 | -- | -- | $0.48 | -- | -- |
06/30/2022 | Q2 | -- | -- | $0.53 | -- | -- |
03/31/2022 | Q1 | -- | -- | $0.49 | -- | -- |
12/31/2021 | Q4 | -- | -- | $0.23 | -- | -- |
09/30/2021 | Q3 | -- | -- | $0.48 | -- | -- |
06/30/2021 | Q2 | -- | -- | $0.56 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.34 | -- | -- |
12/31/2020 | Q4 | -- | -- | $0.27 | -- | -- |
09/30/2020 | Q3 | -- | -- | $0.25 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.20 | -- | -- |
03/31/2020 | Q1 | -- | -- | $0.21 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.08 | -- | -- |
09/30/2019 | Q3 | -- | -- | $0.30 | -- | -- |
06/30/2019 | Q2 | -- | -- | $0.28 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.29 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.19 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.31 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.33 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.35 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.22 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.37 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.42 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.35 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.29 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.38 | -- | -- |
06/30/2016 | Q2 | -- | -- | $0.37 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.28 | -- | -- |
12/31/2015 | Q4 | -- | -- | $0.25 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.27 | -- | -- |
Borregaard ASA reported $198.2M worth of top line sales in its most recent quarter.
Borregaard ASA announced earnings per share of $0.50 which represents a beat of analyst forecast a -- per share.
Borregaard ASA reported -- that represents -- per share over the last quarter.
Borregaard ASA's earnings are forecast to grow from $1.53 per share to -- per share next year representing an increase of --.
Currently, Borregaard ASA has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on October 15, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.